Chat with us, powered by LiveChat

Posts by Jay Kaminski

Cost Considerations: Data Analytics for Biotech Clinical Trials

This week concludes Saama’s Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which has been authored by one of our six new Clinical Board of Advisor members. In this final post, Jay Kaminski  , Chief Operating Officer at Celularity and former Senior Vice President of Global Clinical Research & Development Operations at Celgene Corporation, explores the challenges…

Read More

Related Posts